SOURCE: Prospect Capital Corporation

Prospect Capital Corporation

March 20, 2013 07:00 ET

Prospect Capital Provides $47 Million of Senior Secured Debt to Support the Acquisition of Atlantis Health Care Group (Puerto Rico), Inc. by ICV Partners

NEW YORK, NY--(Marketwire - Mar 20, 2013) - Prospect Capital Corporation (NASDAQ: PSEC) ("Prospect") announced today that Prospect has provided $47 million of senior secured first-lien debt financing to support the acquisition of Atlantis Health Care Group (Puerto Rico), Inc. ("Atlantis") by ICV Partners, a leading investment firm focused on lower middle-market companies. Concurrent with the acquisition, ICV formed American Alliance Dialysis Holdings, LLC ("AAD"), a kidney dialysis treatment platform focused on acquiring, developing, and operating dialysis facilities throughout North America and the Caribbean. 

Headquartered in Trujillo Alto, Puerto Rico, Atlantis was founded in 2000 by Dr. Otegbola Ojo and has since grown into Puerto Rico's second largest provider of kidney dialysis services for patients suffering from end-stage renal disease ("ESRD"). With 13 facilities strategically located throughout the island of Puerto Rico, Atlantis provided approximately 200,000 treatments last year and currently has a patient census of nearly 1,400. Atlantis also contracts with 12 hospital networks to provide inpatient acute dialysis services.

"Prospect played a leadership role with a creative financing solution and efficient transaction execution," said Cory Mims, a Managing Director of ICV Partners. "We have closed numerous transactions with Prospect and continue to book repeat business with Prospect because of our positive experiences."

"Prospect is pleased to support ICV with this important acquisition of a market-leading company that delivers best-of-breed care to its patients," said David Moszer, Managing Director of Prospect Capital Management LLC. "Prospect has completed many healthcare investments in the past several years. We look forward to evaluating other attractive healthcare opportunities and supporting AAD's future growth."

Prospect has closed nearly $700 million of new originations during the current March 2013 quarter, bringing trailing-twelve-month originations to nearly $2.8 billion.

ABOUT PROSPECT CAPITAL CORPORATION

Prospect Capital Corporation (www.prospectstreet.com) is a closed-end investment company that lends to and invests in private and microcap public businesses. Our investment objective is to generate both current income and long-term capital appreciation through debt and equity investments.

We have elected to be treated as a business development company under the Investment Company Act of 1940 ("1940 Act"). We are required to comply with a series of regulatory requirements under the 1940 Act as well as applicable NASDAQ, federal and state rules and regulations. We have elected to be treated as a regulated investment company under the Internal Revenue Code of 1986. Failure to comply with any of the laws and regulations that apply to us could have an adverse effect on us and our shareholders.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.